V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210002598 | 210008431 | 1.54 | 103 | Palliative (P) | 2019-05-13 | 2019-07-09 | Docetaxel | 02 | N | DOCETAXEL | 100537520 |
| 210002599 | 210008432 | 1.58 | 64.3 | null | 2017-09-02 | 2017-11-15 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101220811 |
| 210002600 | 210008433 | null | null | null | 2018-12-03 | 2019-03-11 | PACLITAXEL | 02 | null | PACLITAXEL | 101380924 |
| 210002601 | 210008434 | 1.56 | 94 | null | 2019-05-02 | 2019-07-19 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101074828 |
| 210002602 | 210008435 | 1.63 | 85.1 | Adjuvant (A) | null | 2019-12-20 | Trastuzumab | 02 | N | TRASTUZUMAB | 101510230 |
| 210002603 | 210008436 | 1.47 | 54 | Adjuvant (A) | 2018-10-06 | 2018-10-19 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100301316 |
| 210002604 | 210008437 | null | 70.7 | null | 2018-07-03 | 2018-09-29 | Docetaxel | 02 | null | DOCETAXEL | 100550872 |
| 210002605 | 210008438 | 1.73 | 75 | Palliative (P) | 2016-03-10 | 2016-05-19 | Docetaxel | 02 | null | DOCETAXEL | 100062568 |
| 210002609 | 210008441 | 1.62 | 64.2 | Palliative (P) | null | 2017-01-01 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100649439 |
| 210002610 | 210008442 | 1.75 | 61.3 | Adjuvant (A) | null | 2019-07-09 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101722795 |
| 210002611 | 210008443 | 1.79 | 98.6 | Adjuvant (A) | null | 2020-02-14 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101516640 |
| 210002612 | 210008444 | 1.63 | 70.7 | Adjuvant (A) | null | 2018-07-14 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 100437174 |
| 210002613 | 210008445 | 1.75 | 64 | Adjuvant (A) | 2018-03-24 | 2018-07-10 | Docetaxel | 02 | N | DOCETAXEL | 100176658 |
| 210002614 | 210008446 | null | 62.8 | Adjuvant (A) | null | 2016-10-04 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101380607 |
| 210002615 | 210008447 | 1.68 | 76.25 | null | 2019-09-24 | 2020-01-15 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 101606428 |
| 210002618 | 210008449 | 1.63 | 84.3 | Curative (C) | 2016-03-29 | 2016-06-02 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101791657 |
| 210002619 | 210008450 | 1.57 | 62.7 | Adjuvant (A) | null | 2018-11-21 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100723465 |
| 210002620 | 210008451 | 1.73 | 74 | null | 2015-11-27 | 2016-08-22 | Trastuzumab | 02 | N | TRASTUZUMAB | 100961564 |
| 210002621 | 210008452 | null | null | Palliative (P) | null | 2019-03-07 | Paclitaxel 7 day | null | N | PACLITAXEL | 100980853 |
| 210002623 | 210008454 | 1.59 | 101.1 | null | 2017-04-07 | 2017-05-12 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 101029144 |
| 210002624 | 210008455 | null | 77.5 | Neo-adjuvant (N) | 2018-03-06 | 2018-03-07 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 100432041 |
| 210002628 | 210008457 | 1.69 | 70.25 | null | 2018-06-15 | 2018-07-15 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101416903 |
| 210002630 | 210008459 | 1.58 | 98.8 | Neo-adjuvant (N) | 2020-05-04 | 2020-07-07 | PACLITAXEL | 02 | N | PACLITAXEL | 101833000 |
| 210002631 | 210008460 | 1.62 | 50.4 | Adjuvant (A) | null | 2020-08-04 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100800558 |
| 210002632 | 210008461 | 1.63 | 100.3 | Adjuvant (A) | 2016-10-24 | 2017-01-02 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100208875 |
| 210002633 | 210008462 | 1.73 | 64 | null | 2017-02-03 | 2017-05-10 | Docetaxel | 02 | null | DOCETAXEL | 100957328 |
| 210002634 | 210008463 | 1.67 | null | Adjuvant (A) | 2021-02-25 | 2021-02-28 | PACLITAXEL | null | N | PACLITAXEL | 100165613 |
| 210002635 | 210008464 | 1.54 | 66.3 | Adjuvant (A) | 2022-05-01 | 2022-05-16 | Trastuzumab | 02 | null | TRASTUZUMAB | 101295030 |
| 210002636 | 210008465 | 1.72 | 85.3 | null | null | 2019-09-16 | Trastuzumab | 01 | null | TRASTUZUMAB | 100183183 |
| 210002637 | 210008466 | null | 73 | Adjuvant (A) | null | 2020-02-17 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 101493616 |
| 210002639 | 210008468 | 1.65 | 107.5 | Neo-adjuvant (N) | 2017-03-05 | 2017-03-11 | EC | N | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101227330 |
| 210002641 | 210008470 | 1.53 | 81.8 | null | 2019-10-09 | 2020-02-03 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | PACLITAXEL | 100385496 |
| 210002643 | 210008471 | 1.62 | 56.6 | Adjuvant (A) | null | 2017-03-01 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100274856 |
| 210002644 | 210008472 | 1.63 | 65.2 | Palliative (P) | null | 2018-10-21 | Docetaxel | null | N | DOCETAXEL | 101704040 |
| 210002648 | 210008473 | 1.51 | 75 | Unknown (U) | 2018-08-30 | 2018-11-15 | Docetaxel | null | N | DOCETAXEL | 101843835 |
| 210002650 | 210008474 | 1.56 | 70 | Adjuvant (A) | null | 2017-02-20 | Docetaxel | 02 | N | DOCETAXEL | 100570355 |
| 210002651 | 210008475 | 1.75 | 0 | Neo-adjuvant (N) | 2019-01-11 | 2019-02-03 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100764006 |
| 210002652 | 210008476 | 1.55 | 115 | null | null | 2019-07-23 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101398824 |
| 210002653 | 210008477 | null | null | null | null | 2018-04-26 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 100093279 |
| 210002655 | 210008478 | null | 61.6 | Palliative (P) | 2021-02-20 | 2021-05-05 | EC | N | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100056063 |
| 210002657 | 210008479 | null | 46.4 | null | 2019-11-10 | 2019-11-22 | Trastuzumab Subcutaneous | N | null | TRASTUZUMAB | 101287575 |
| 210002659 | 210008480 | 1.64 | 98.5 | Palliative (P) | 2020-11-04 | 2020-11-05 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100644853 |
| 210002660 | 210008481 | 1.64 | null | null | 2018-09-16 | 2018-12-10 | PACLITAXEL | 02 | N | PACLITAXEL | 101045872 |
| 210002662 | 210008483 | null | 58 | Adjuvant (A) | 2017-08-23 | 2018-11-02 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 101694590 |
| 210002663 | 210008484 | 1.65 | 53.7 | Adjuvant (A) | 2018-12-21 | 2018-12-31 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100836789 |
| 210002669 | 210008485 | 1.54 | null | Palliative (P) | 2018-12-27 | 2019-03-31 | Trastuzumab | null | N | TRASTUZUMAB | 101746297 |
| 210002670 | 210008486 | 1.63 | 84.3 | Adjuvant (A) | null | 2018-12-11 | PACLITAXEL | 02 | N | PACLITAXEL | 100535601 |
| 210002671 | 210008487 | 1.62 | 78 | Adjuvant (A) | 2018-06-12 | 2019-11-10 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100432042 |
| 210002672 | 210008488 | 1.64 | 79.3 | Curative (C) | 2018-05-21 | 2018-08-14 | PACLITAXEL | 02 | null | PACLITAXEL | 101420735 |
| 210002674 | 210008489 | 1.6 | 85.8 | Palliative (P) | 2018-04-03 | 2018-04-19 | Trastuzumab | 02 | N | TRASTUZUMAB | 101657779 |